BISPECIFIC ANTIBODY THAT BINDS TO CD116 AND CD131

The purpose of the present invention is to provide a bispecific antibody and a fragment of said bispecific antibody that have an agonist activity against GM-CSF receptors. The present invention relates to a bispecific antibody, or a fragment of said bispecific antibody, including a first antigen bin...

Full description

Saved in:
Bibliographic Details
Main Authors HARUMOTO Toshimasa, NISHIYA Harue, KATO Akifumi, NAKANO Ryosuke
Format Patent
LanguageEnglish
Published 14.03.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The purpose of the present invention is to provide a bispecific antibody and a fragment of said bispecific antibody that have an agonist activity against GM-CSF receptors. The present invention relates to a bispecific antibody, or a fragment of said bispecific antibody, including a first antigen binding domain and a second antigen binding domain, wherein one of the first antigen binding domain and the second antigen binding domain is an antigen binding domain that binds to CD116, and the other is an antigen binding domain that binds to CD131.
Bibliography:Application Number: AU20220332728